Novel glucagon-like peptide-1 (GLP-1) analog (Val<sup>8</sup>)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (<i>ob/ob</i>) mice.
Data(s) |
01/04/2006
|
---|---|
Identificador |
http://dx.doi.org/10.1124/jpet.105.097824 http://www.scopus.com/inward/record.url?scp=33745937115&partnerID=8YFLogxK |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Green , B , Flatt , P R , Lavery , K , Irwin , N , O'Harte , F P M , Harriott , P , Greer , B & Bailey , C J 2006 , ' Novel glucagon-like peptide-1 (GLP-1) analog (Val 8 )GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic ( ob/ob ) mice. ' Journal of Pharmacology and Experimental Therapeutics , vol 318(2) , no. 2 , pp. 914-921 . DOI: 10.1124/jpet.105.097824 |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/3000/3004 #Pharmacology |
Tipo |
article |